Reimbursement Challenges and Solutions with Molecular Biomarker Testing

Geoffrey R. Oxnard, MD; Lauren L. Ritterhouse, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Drs. Geoffrey Oxnard and Lauren Ritterhouse consider the current landscape of reimbursement for molecular biomarker testing, the need to run FDA-approved tests, and the role of CMS and local Medicare providers in testing reimbursement.

Related Videos

October 8, 2014

Success and Failure on PV Treatment Approach

Listen as Dr. Michaelis presents her opinion on success and failure approach to treatment of polycythemia vera. Supported through funding from Incyte

October 8, 2014

Importance of Cytoreductive Therapy

Laura C. Michaelis, MD, Medical College of Wisconsin describes why cytoreductive therapy is important to discuss with patients with polycthemia vera.Supported through funding from Incyte